Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/164191
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGonzález Pizarro, Roberto Carlos-
dc.contributor.authorParrotta, Graziella-
dc.contributor.authorVera-García, Rodrigo-
dc.contributor.authorSánchez-López, E. (Elena)-
dc.contributor.authorGalindo Camacho, Ruth Milagros-
dc.contributor.authorKjeldsen, Frank-
dc.contributor.authorBadía Palacín, Josefa-
dc.contributor.authorBaldomà Llavinés, Laura-
dc.contributor.authorEspina García, Marta-
dc.contributor.authorGarcía López, María Luisa-
dc.date.accessioned2020-06-04T07:37:28Z-
dc.date.available2020-11-26T06:10:20Z-
dc.date.issued2019-11-26-
dc.identifier.issn1743-5889-
dc.identifier.urihttp://hdl.handle.net/2445/164191-
dc.description.abstractAim: Development of fluorometholone-loaded PEG-PLGA nanoparticles (NPs) functionalized with cellpenetrating peptides for the treatment of ocular inflammatory disorders. Materials & methods: Synthesized polymers and peptides were used for elaboration of functionalized NPs, which were characterized physicochemically. Cytotoxicity and ability to modulate the expression of proinflammatory cytokines were evaluated in vitro using human corneal epithelial cells (HCE-2). NP uptake was assayed in both in vitro and in vivo models. Results: NPs showed physicochemical characteristics suitable for ocular administration without evidence of cytotoxicity. TAT-NPs and G2-NPs were internalized and displayed anti-inflammatory activity in both HCE-2 cells and mouse eye. Conclusion: TAT-NPs and G2-NPs could be considered a novel strategy for the treatment of ocular inflammatory diseases of the anterior and posterior segment.-
dc.format.extent16 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFuture Medicine-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.2217/nnm-2019-0201-
dc.relation.ispartofNanomedicine, 2019, vol. 14, num. 23, p. 3089-3104-
dc.relation.urihttps://doi.org/10.2217/nnm-2019-0201-
dc.rights(c) Future Medicine, 2019-
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)-
dc.subject.classificationFarmacologia ocular-
dc.subject.classificationAgents antiinflamatoris-
dc.subject.classificationSistemes d'alliberament de medicaments-
dc.subject.classificationNanopartícules-
dc.subject.classificationUveïtis-
dc.subject.classificationPolímers-
dc.subject.classificationPèptids-
dc.subject.otherOcular pharmacology-
dc.subject.otherAntiinflammatory agents-
dc.subject.otherDrug delivery systems-
dc.subject.otherNanoparticles-
dc.subject.otherUveitis-
dc.subject.otherPolymers-
dc.subject.otherPeptides-
dc.titleOcular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec694447-
dc.date.updated2020-06-04T07:37:29Z-
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/646603/EU//METALS-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Bioquímica i Fisiologia)
Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
694447.pdf7.48 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.